SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-012501
Filing Date
2018-05-09
Accepted
2018-05-09 17:02:09
Documents
57
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q vktx-10q_20180331.htm 10-Q 1709037
2 EX-31.1 vktx-ex311_8.htm EX-31.1 20478
3 EX-31.2 vktx-ex312_6.htm EX-31.2 20568
4 EX-32.1 vktx-ex321_7.htm EX-32.1 12837
  Complete submission text file 0001564590-18-012501.txt   7314312

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT vktx-20180331.xml EX-101.INS 1746844
6 XBRL TAXONOMY EXTENSION SCHEMA vktx-20180331.xsd EX-101.SCH 52697
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vktx-20180331_cal.xml EX-101.CAL 37755
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vktx-20180331_def.xml EX-101.DEF 185835
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE vktx-20180331_lab.xml EX-101.LAB 394590
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vktx-20180331_pre.xml EX-101.PRE 323196
Mailing Address 12340 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130
Business Address 12340 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130 858-704-4660
Viking Therapeutics, Inc. (Filer) CIK: 0001607678 (see all company filings)

IRS No.: 461073877 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37355 | Film No.: 18819248
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences